Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/1998
03/18/1998EP0828833A1 Chemokine n-terminal deletion mutations
03/18/1998EP0828828A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
03/18/1998EP0828742A1 Diazepino-indoles as phosphodiesterase iv inhibitors
03/18/1998EP0828736A1 Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
03/18/1998EP0828732A1 Peptidyl compounds and their therapeutic use
03/18/1998EP0828730A1 Piperazine derivatives
03/18/1998EP0828728A1 Phenyl dihydrobenzofuranes
03/18/1998EP0828727A1 Cyclohexyl dihydrobenzofuranes
03/18/1998EP0828726A1 Tricyclic inhibitors of matrix metalloproteinases
03/18/1998EP0828724A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
03/18/1998EP0828493A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
03/18/1998EP0828488A1 Isothiazolones
03/18/1998EP0598753B1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
03/18/1998EP0590009B1 Dialkyl (dialkoxyphosphinyl)methyl phosphates as anti-inflammatory agents
03/18/1998CN1176598A Method and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
03/18/1998CN1037773C Heteroatoms-containing tricyclic compounds
03/17/1998US5728846 Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
03/17/1998US5728845 Immunotherapeutic nitriles
03/17/1998US5728844 Immunotherapeutic agents
03/17/1998US5728826 Silation of pregnadienes, fractional crystallization to separate enantiomers
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728716 Trachykinin peptide for nervous system disorders and cardiovascular disorders
03/17/1998US5728708 Pharmacologically active pyridine derivatives and processes for the preparation thereof
03/17/1998US5728695 Tachykinin antagonists useful in treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
03/17/1998US5728686 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals
03/17/1998US5728685 Selectin receptors for inflammation modulators
03/17/1998US5728677 Administering a specified polypeptide to a mammal
03/17/1998US5728676 Use of insulin-like growth factors I and II for inhibition of inflammatory response
03/17/1998US5728568 Human GDP-mannose 4,6 dehydratase
03/17/1998CA1339724C Anti-inflammatory factor, method of isolation, and use
03/12/1998WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
03/12/1998WO1998009985A2 Anti-inflammatory peptides and uses thereof
03/12/1998WO1998009984A1 Central nervous system-derived immune privilege factor and uses thereof
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use
03/12/1998WO1998009970A2 Alkylated rapamycin derivatives
03/12/1998WO1998009969A1 Novel aryl-pyridazines
03/12/1998WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998WO1998009957A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998WO1998009948A2 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998WO1998009946A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
03/12/1998WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
03/12/1998WO1998009934A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998WO1998009653A1 Association of no syntase inhibitors with trappers of oxygen reactive forms
03/12/1998WO1998009630A1 Compounds and methods
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009620A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-λB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1998009526A1 Antioxidant derived from lentil and its preparation and uses
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998DE19636150A1 N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung N-substituted indole-3-glyoxylamides with anti-asthmatic, anti-allergic and immunosuppressive / immunomodulatory effect
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2592537A1 Nitric ester derivatives in the treatment of inflammatory diseases
03/12/1998CA2591612A1 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998CA2266039A1 Alkylated rapamycin derivatives
03/12/1998CA2264959A1 Central nervous system-derived immune privilege factor and uses thereof
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264285A1 Anti-inflammatory peptides and uses thereof
03/12/1998CA2264081A1 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2263586A1 Novel aryl-pyridazines
03/12/1998CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998CA2256631A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/11/1998EP0827747A1 Analgetic agent
03/11/1998EP0827741A2 Composition for transdermal delivery system containing nonsteroidal anti-inflammatory drug as an active ingredient
03/11/1998EP0827412A1 Peptide radiopharmaceutical applications
03/11/1998EP0827404A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis
03/11/1998EP0827400A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
03/11/1998EP0827399A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
03/11/1998EP0666757B1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
03/11/1998CN1175944A 1 -aryl -2 -acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
03/11/1998CN1175437A Wind-expelling medicinal liquor
03/10/1998US5726312 Methods for preparing antiproliferative 5-substituted pyrimidone compounds
03/10/1998US5726302 Water soluble adenosine kinase inhibitors
03/10/1998US5726175 Imidazo 1,2-A!indeno 1,2-E!pyrazine-2-carboxylic acid derivatives, preparation thereof and drugs containing same
03/10/1998US5726158 Peptide derivatives
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/05/1998WO1998008966A1 Loxoprofen-containing preparation for external use
03/05/1998WO1998008949A1 P-selectin ligand proteins
03/05/1998WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008841A1 New thiazole derivatives with phosphodiesterase-inhibiting effect
03/05/1998WO1998008840A1 Integrin antagonists
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008826A1 Piperazino derivatives as neurokinin antagonists
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008822A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998WO1998008818A1 Inhibitors of phospholipase enzymes
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008814A1 Bidentate metalloprotease inhibitors
03/05/1998WO1998008546A2 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998WO1998008538A1 Use of hyaluronidase
1 ... 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 ... 1272